Download PDF
Thromb Haemost 1996; 75(06): 975-976
DOI: 10.1055/s-0038-1650406
Letter to the Editor
Schattauer GmbH Stuttgart

Arg 506 Gin Factor V Mutation (Factor V Leiden) in Patients with Familial Hypercholesterolaemia

Alpo Vuorio
1   Department of Medicine, University of Helsinki, Helsinki, Finland
,
Hannu Turtola
2   Central Hospital of North Karelia, Joensuu, Finland
,
Kimmo Kontula
1   Department of Medicine, University of Helsinki, Helsinki, Finland
› Author Affiliations
Further Information

Publication History

Received 25 August 1995

Accepted after resubmission 19 February 1996

Publication Date:
11 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedGoogle Scholar
  • 2 Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thromobophilia Study. Lancet 1993; 342: 1503-1506
    CrossrefPubMedGoogle Scholar
  • 3 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 4 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
    CrossrefPubMedGoogle Scholar
  • 5 Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-917
    CrossrefPubMedGoogle Scholar
  • 6 Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Makelin R, Hamalainen L, Palomaki H, Kaste M. Arg 506 Gin factor V mutation (Factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995; 73: 558-560
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Van Bockxmeer FM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation factor V. Nature Med 1995; 1: 185
    CrossrefPubMedGoogle Scholar
  • 8 Catto A, Carter A, Ireland H, Bayston TA, Philippou H, Barrett J, Lane DA, Grant PJ. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vase Biol 1995; 15: 783-785
    CrossrefPubMedGoogle Scholar
  • 9 Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1: 445-466
    CrossrefPubMedGoogle Scholar
  • 10 Nikkila EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet 1973; i: 954-959
    PubMedGoogle Scholar
  • 11 Koivisto U-M, Hamalainen L, Taskinen M-R, Kettunen K, Kontula K. Prevalence of familial hypercholesterolemia among young North Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction. J Lipid Res 1993; 34: 269-277
    PubMedGoogle Scholar
  • 12 Aalto-Setala K, Helve E, Kovanen PT, Kontula K. Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype. J Clin Invest 1989; 84: 499-505
    CrossrefPubMedGoogle Scholar
  • 13 Koivisto U-M, Turtola H, Aalto-Setala K, Top B, Frants RR, Kovanen PT, Syvanen A-C, Kontula K. The FH-North Karelia mutation of the low density lipoprotein receptor deletes seven nucleotides of exon 6 and is a common cause of familial hypercholesterolemia in Finland. J Clin Invest 1992; 90: 219-228
    CrossrefPubMedGoogle Scholar